Literature DB >> 7611234

Marked improvement in cholestasis and hypercholesterolemia with simvastatin in a patient with primary biliary cirrhosis.

T Kamisako, Y Adachi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7611234

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN： 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  6 in total

1.  Effects of statins on cholestasis: good, bad or indifferent?

Authors:  Rahul Kuver
Journal:  J Gastroenterol Hepatol       Date:  2011-10       Impact factor: 4.029

Review 2.  Use of Statins in Patients with Chronic Liver Disease and Cirrhosis: Current Views and Prospects.

Authors:  Jose Ignacio Vargas; Marco Arrese; Vijay H Shah; Juan Pablo Arab
Journal:  Curr Gastroenterol Rep       Date:  2017-09

3.  Hyperlipidemia in Chronic Cholestatic Liver Disease.

Authors:  Matteo Longo; Andrea Crosignani; Mauro Podda
Journal:  Curr Treat Options Gastroenterol       Date:  2001-04

Review 4.  Nuclear receptors as therapeutic targets in cholestatic liver diseases.

Authors:  Gernot Zollner; Michael Trauner
Journal:  Br J Pharmacol       Date:  2009-01       Impact factor: 8.739

5.  Atorvastatin does not improve liver biochemistries or Mayo Risk Score in primary biliary cirrhosis.

Authors:  Carmen M Stanca; Nancy Bach; Jorge Allina; Carol Bodian; Henry Bodenheimer; Joseph A Odin
Journal:  Dig Dis Sci       Date:  2008-04-05       Impact factor: 3.199

Review 6.  Nuclear receptors as drug targets in cholestatic liver diseases.

Authors:  Emina Halilbasic; Anna Baghdasaryan; Michael Trauner
Journal:  Clin Liver Dis       Date:  2013-05       Impact factor: 6.126
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.